Loading organizations...
Key people at Adamed.
Adamed was founded in 1986 by Marian Adamkiewicz (Founder).
Adamed is a pharmaceutical and biotechnology firm developing and manufacturing a diverse portfolio of medicinal products. The company focuses on addressing chronic civilization diseases across various therapeutic areas, leveraging its proprietary scientific advancements and extensive patent portfolio. Its technical approach emphasizes continuous innovation, including the development of both original and value-added medicines, supported by significant investment in research and development.
The company was founded in 1986 by Marian Adamkiewicz, MD, PhD. Adamed originated from an insight into the potential of Polish scientific thought to create impactful pharmaceutical solutions. This foundation enabled the company to grow into a major player within the Polish pharmaceutical landscape and an early adopter of innovative therapeutic research, beginning in the early 2000s.
Adamed's products serve patients globally, providing essential medications, over-the-counter drugs, dietary supplements, dermocosmetics, and medical devices. The company’s vision is centered on responding to the key challenges of modern medicine by providing high-quality products. It aims to improve patient health and well-being through ongoing innovation and strategic expansion into new markets.
Key people at Adamed.
Adamed was founded in 1986 by Marian Adamkiewicz (Founder).
Adamed has 1 tracked investment across 1 company. The latest tracked deal is $7.0M Series A in Telemedi in January 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2021 | Telemedi | $7.0M Series A | Adamed, Black Pearls VC, Michael Szalontay, PKO VC, Andreas Nemeth | TJ Nahigian, Cedar Capital Group, Flashpoint VC, Gradient Ventures, Matrix Capital |